Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000494:pharmacology*; D002118:Calcium / Q000097:blood; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000188:drug therapy; D004872:Ergocalciferols / Q000097:blood; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000097:blood; D006996:Hypocalcemia / Q000139:chemically induced / Q000517:prevention & control; D007527:Isoenzymes / Q000097:blood; D008297:Male; D010634:Phenobarbital / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010710:Phosphates / Q000097:blood; D012709:Serum Albumin / Q000032:analysis; D013472:Sunlight; D013997:Time Factors; D014807:Vitamin D / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use
D000927:Anticonvulsants; D004872:Ergocalciferols; D006887:Hydroxycholecalciferols; D007527:Isoenzymes; D010710:Phosphates; D012709:Serum Albumin; D014807:Vitamin D; D010672:Phenytoin; D000469:Alkaline Phosphatase; D002118:Calcium; D010634:Phenobarbital